Kidney-targeted drug delivery via rhein-loaded polyethyleneglycol-co-polycaprolactone-co-polyethylenimine nanoparticles for diabetic nephropathy therapy

References

• Fernandez-FernandezBOrtizAGomez-GuerreroCEgidoJTherapeutic approaches to diabetic nephropathy-beyond the RASNat Rev Nephrol201410632534624802062
   PubMed Web of Science ®Google Scholar
• KatoMNatarajanRDiabetic nephropathy-emerging epigenetic mechanismsNat Rev Nephrol201410951753025003613
   PubMed Web of Science ®Google Scholar
• HuCSunLXiaoLInsights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathyCurr Med Chem201522242858287026119175
   PubMed Web of Science ®Google Scholar
• Navarro-GonzálezJFMora-FernándezCMuros de FuentesMGarcía-PérezJInflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNat Rev Nephrol20117632734021537349
   PubMed Web of Science ®Google Scholar
• KanwarYSSunLXiePLiuFYChenSA glimpse of various pathogenetic mechanisms of diabetic nephropathyAnnu Rev Pathol2011639542321261520
   PubMed Web of Science ®Google Scholar
• Martínez-CastelaoANavarro-GonzálezJFGórrizJLde AlvaroFThe concept and the epidemiology of diabetic nephropathy have changed in recent yearsJ Clin Med2015461207121626239554
   PubMed Web of Science ®Google Scholar
• ReddyMANatarajanRRecent developments in epigenetics of acute and chronic kidney diseasesKidney Int201588225026125993323
   PubMed Web of Science ®Google Scholar
• SaranRRobinsonBAbbottKCUS Renal Data System 2016 annual data report: epidemiology of kidney disease in the United StatesAm J Kidney Dis2017693 suppl 1A7A828236831
   PubMed Web of Science ®Google Scholar
• LorenzenJMHallerHThumTMicroRNAs as mediators and therapeutic targets in chronic kidney diseaseNat Rev Nephrol20117528629421423249
   PubMed Web of Science ®Google Scholar
• GuoXHLiuZHDaiCSLiHLiuDLiLSRhein inhibits renal tubular epithelial cell hypertrophy and extracellular matrix accumulation induced by transforming growth factor beta1Acta Pharmacol Sin2001221093493811749778
   PubMed Web of Science ®Google Scholar
• PengLYangJNingCRhein inhibits integrin-linked kinase expression and regulates matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in high glucose-induced epithelial-mesenchymal transition of renal tubular cellBiol Pharm Bull201235101676168523037158
   PubMed Web of Science ®Google Scholar
• GaoQQinWSJiaZHRhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathyPlanta Med2010761273319639539
   PubMed Web of Science ®Google Scholar
• ZhengJMZhuJMLiLSLiuZHRhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathwayBr J Pharmacol200815371456146418264122
   PubMed Web of Science ®Google Scholar
• XuSLvYZhaoJWangJZhaoXWangSInhibitory effects of Shenkang injection and its main component emodin on the proliferation of high glucose-induced renal mesangial cells through cell cycle regulation and induction of apoptosisMol Med Rep20161443381338827572472
   PubMed Web of Science ®Google Scholar
• ShiSCaiYCaiXA network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney diseasePLoS One201493e8912324598793
   PubMed Web of Science ®Google Scholar
• HeDLeeLYangJWangXPreventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathyBiol Pharm Bull20113481219122621804209
   PubMed Web of Science ®Google Scholar
• ZengCCLiuXChenGRThe molecular mechanism of rhein in diabetic nephropathyEvid Based Complement Alternat Med2014201448709725435889
   PubMed Web of Science ®Google Scholar
• WangJZhaoYXiaoXAssessment of the renal protection and hepatotoxicity of rhubarb extract in ratsJ Ethnopharmacol20091241182519376216
   PubMed Web of Science ®Google Scholar
• HeLNYangAHCuiTYReactive metabolite activation by CYP2C19-mediated rhein hepatotoxicityXenobiotica201545436137225815638
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• KamalyNYameenBWuJFarokhzadOCDegradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug releaseChem Rev201611642602266326854975
   PubMed Web of Science ®Google Scholar
• PelazBAlexiouCAlvarez-PueblaRADiverse applications of nanomedicineACS Nano20171132313238128290206
   PubMed Web of Science ®Google Scholar
• TorchilinVPMultifunctional, stimuli-sensitive nanoparticulate systems for drug deliveryNat Rev Drug Discov2014131181382725287120
   PubMed Web of Science ®Google Scholar
• WilhelmSTavaresAJDaiQAnalysis of nanoparticle delivery to tumoursNat Rev Mater20161516014
   Web of Science ®Google Scholar
• KimYKKwonJTJiangHLChoiYJChoMHChoCSKidney-specific peptide-conjugated poly (ester amine) for the treatment of kidney fibrosisJ Nanosci Nanotechnol20121275149515422966536
   PubMed Web of Science ®Google Scholar
• LinYLiYWangXGongTZhangLSunXTargeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamineJ Control Release2013167214815623415893
   PubMed Web of Science ®Google Scholar
• ZhangZZhengQHanJThe targeting of 14-succinate triptolidelysozyme conjugate to proximal renal tubular epithelial cellsBiomaterials20093071372138119100618
   PubMed Web of Science ®Google Scholar
• ZuckermanJEGaleAWuPMaRDavisMEsiRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNANucleic Acid Ther2015252536425734248
   PubMed Web of Science ®Google Scholar
• KamalyNHeJCAusielloDAFarokhzadOCNanomedicines for renal disease: current status and future applicationsNat Rev Nephrol2016121273875327795549
   PubMed Web of Science ®Google Scholar
• WangJMasehi-LanoJJChungEJPeptide and antibody ligands for renal targeting: nanomedicine strategies for kidney diseaseBiomater Sci2017581450145928516997
   PubMed Web of Science ®Google Scholar
• ChoiCHZuckermanJEWebsterPDavisMETargeting kidney mesangium by nanoparticles of defined sizeProc Natl Acad Sci U S A2011108166656666121464325
   PubMed Web of Science ®Google Scholar
• ZuckermanJEDavisMETargeting therapeutics to the glomerulus with nanoparticlesAdv Chronic Kidney Dis201320650050724206602
   PubMed Web of Science ®Google Scholar
• DuBJiangXDasAGlomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regimeNat Nanotechnol201712111096110428892099
   PubMed Web of Science ®Google Scholar
• BruniRPossentiPBordignonCUltrasmall polymeric nanocarriers for drug delivery to podocytes in kidney glomerulusJ Control Release20172559410728395969
   PubMed Web of Science ®Google Scholar
• GuoLLuoSDuZTargeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritisNat Commun20178187829026082
   PubMed Web of Science ®Google Scholar
• YuanZGuXPreparation, characterization, and in vivo study of rheinloaded poly (lactic-co-glycolic acid) nanoparticles for oral deliveryDrug Des Devel Ther2015923012309
   PubMed Web of Science ®Google Scholar
• WeiYLuoXGuanJBiodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokineticsDrug Dev Ind Pharm201743111885189128692315
   PubMed Web of Science ®Google Scholar
• SunQZhouZQiuNShenYRational design of cancer nanomedicine: nanoproperty integration and synchronizationAdv Mater20172914
   Web of Science ®Google Scholar
• SeoSJChenMWangHKangMSLeongKWKimH-WExtra-and intra-cellular fate of nanocarriers under dynamic interactions with biologyNano Today2017148499
   Web of Science ®Google Scholar
• YameenBChoiWIVilosCSwamiAShiJFarokhzadOCInsight into nanoparticle cellular uptake and intracellular targetingJ Control Release201419048549924984011
   PubMed Web of Science ®Google Scholar
• VarkouhiAKScholteMStormGHaismaHJEndosomal escape pathways for delivery of biologicalsJ Control Release2011151322022821078351
   PubMed Web of Science ®Google Scholar
• AkincAThomasMKlibanovAMLangerRExploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesisJ Gene Med20057565766315543529
   PubMed Web of Science ®Google Scholar
• BolettaABenigniALutzJRemuzziGSoriaMRMonacoLNonviral gene delivery to the rat kidney with polyethylenimineHum Gene Ther1997810124312519215741
   PubMed Web of Science ®Google Scholar
• GodbeyWTWuKKMikosAGTracking the intracellular path of poly (ethylenimine)/DNA complexes for gene deliveryProc Natl Acad Sci U S A19999695177518110220439
   PubMed Web of Science ®Google Scholar
• AstafievaIZhongXFEisenbergACritical micellization phenomena in block polyelectrolyte solutionsMacromolecules1993262673397352
   Web of Science ®Google Scholar
• DobrovolskaiaMAClogstonJDNeunBWHallJBPatriAKMcNeilSEMethod for analysis of nanoparticle hemolytic properties in vitroNano Lett2008882180218718605701
   PubMed Web of Science ®Google Scholar
• AminKDannenfelserRMIn vitro hemolysis: guidance for the pharmaceutical scientistJ Pharm Sci20069561173117616639718
   PubMed Web of Science ®Google Scholar
• BreyerMDBöttingerEBrosiusFCIIIAMDCCMouse models of diabetic nephropathyJ Am Soc Nephrol2005161274515563560
   PubMed Web of Science ®Google Scholar
• FurmanBLStreptozotocin-induced diabetic models in mice and ratsCurr Protoc Pharmacol201570 5.47120
   Google Scholar
• Sigaudo-RousselDFromyBSaumetJLDiabetic neuropathy in animal modelsDrug Discov Today Dis Models2007413944
   Google Scholar
• TeschGHAllenTJRodent models of streptozotocin-induced diabetic nephropathy (methods in renal research)Nephrology200712326126617498121
   PubMed Web of Science ®Google Scholar
• GrassiMGrassiGApplication of mathematical modeling in sustained release delivery systemsExpert Opin Drug Deliv20141181299132124938598
   PubMed Web of Science ®Google Scholar
• FischerDLiYAhlemeyerBKrieglsteinJKisselTIn vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysisBiomaterials20032471121113112527253
   PubMed Web of Science ®Google Scholar
• MayrJBachlJSchlossmannJDíazDDAntimicrobial and hemolytic studies of a series of polycations bearing quaternary ammonium moieties: structural and topological effectsInt J Mol Sci2017182303
   PubMed Web of Science ®Google Scholar
• BenjaminsenRVMattebjergMAHenriksenJRThe possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pHMol Ther201321114915723032976
   PubMed Web of Science ®Google Scholar
• PuttaSLantingLSunGLawsonGKatoMNatarajanRInhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathyJ Am Soc Nephrol201223345846922223877
   PubMed Web of Science ®Google Scholar
• MengXMTangPMKLiJTGF-β/Smad signaling in renal fibrosisFront Physiol201568225852569
   PubMed Web of Science ®Google Scholar
• LoefflerIWolfGTransforming growth factor-β and the progression of renal diseaseNephrol Dial Transplant201329Suppl 1i37i4524030832
   PubMedGoogle Scholar
• MengXMChungACKLanHYRole of the TGF-β/BMP-7/Smad pathways in renal diseasesClin Sci2013124424325423126427
   PubMed Web of Science ®Google Scholar
• MengXNikolic-PatersonDJLanHYTGF-β: the master regulator of fibrosisNat Rev Nephrol201612632533827108839
   PubMed Web of Science ®Google Scholar
• ReddyBYadavHKSNageshaDKRaizadayAKarimAPolymeric micelles as novel carriers for poorly soluble drugsJ Nanosci Nanotechnol20151564009401826369007
   PubMed Web of Science ®Google Scholar
• ShiYMillerMLDi PasquaAJBiocompatibility of mesoporous silica nanoparticles?Comments Inorg Chem20163626180
   Web of Science ®Google Scholar
• MartensTFRemautKDemeesterJDe SmedtSBraeckmansKIntracellular delivery of nanomaterials: how to catch endosomal escape in the actNano Today201493344364
   Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• DolmanMEHarmsenSStormGHenninkWEKokRJDrug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cellsAdv Drug Deliv Rev201062141344135720719242
   PubMed Web of Science ®Google Scholar
• BowenTJenkinsRHFraserDJMicroRNAs, transforming growth factor beta-1, and tissue fibrosisJ Pathol2013229227428523042530
   PubMed Web of Science ®Google Scholar
• GomezIGMacKennaDAJohnsonBGAnti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathwaysJ Clin Invest2015125114115625415439
   PubMed Web of Science ®Google Scholar
• TrionfiniPBenigniARemuzziGMicroRNAs in kidney physiology and diseaseNat Rev Nephrol2015111233325385286
   PubMed Web of Science ®Google Scholar